Regeneron News, Regeneron Quote, REGN Quote

Regeneron (NQ:REGN) Delayed: 1015.67 +16.65 (1.67%)

Prev. Close

$999.02

Open

$1003.31

52 Wk High

$592.36

52 Wk Low

$325.35

Day High

$1017.74

Day Low

$996.28

P/E

266.58

EPS

$3.81

Volume

482,155

Friends, Peers and Foes (?): AMGN, SNY, SAN, LLY, MRNA (more...)

Oct 11, 2024 08:25 AM Regeneron Pharma (REGN) PT Lowered to $1,235 at Morgan Stanley
Oct 7, 2024 07:00 AM Form 8-K REGENERON PHARMACEUTICAL For: Oct 07
Oct 3, 2024 04:02 PM Form 4 REGENERON PHARMACEUTICAL For: Oct 01 Filed by: RYAN ARTHUR F
Oct 3, 2024 04:02 PM Form 4 REGENERON PHARMACEUTICAL For: Oct 01 Filed by: McCourt Marion
Oct 1, 2024 04:13 PM Form 144 REGENERON PHARMACEUTICAL Filed by: McCourt Marion
Sep 30, 2024 08:29 AM BMO Capital Reiterates Outperform Rating on Regeneron Pharma (REGN)
Sep 30, 2024 07:16 AM Erste Group Downgrades Regeneron Pharma (REGN) to Hold, 'sales growth will be impaired'
Sep 30, 2024 06:22 AM TD Cowen Reiterates Buy Rating on Regeneron Pharma (REGN)
Sep 27, 2024 11:51 AM TD Cowen Reiterates Buy Rating on Regeneron Pharma (REGN)
Sep 27, 2024 09:35 AM Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD

Entities mentioned with REGN